Irkutsk, Irkutsk region, Russian Federation
Irkutsk State Medical Academy of Postgraduate Education (Department of Pedagogical and Information Technologies, Head)
Irkutsk, Irkutsk region, Russian Federation
Sravnivalis' rezul'taty kompleksnogo (medikamentoznogo i hirurgicheskogo) i medikamentoznogo lecheniya pacientov s bystroprogressiruyuschey i associirovannoy s diskineziyami formoy bolezni Parkinsona. Predlozheny indeksy atrofii (IA) veschestva golovnogo mozga dlya obosnovaniya differencirovannogo podhoda v lechenii kazhdoy iz form. Po rezul'tatam mnogofaktornogo regressionnogo analiza opredeleny znacheniya, pri kotoryh effekt kompleksnogo lecheniya maksimal'nyy. Takzhe opredeleny znacheniya IA, pri kotoryh rezul'tat byl prakticheski postoyannym v techenie 1,5 let nablyudeniya.
bolezn' Parkinsona, diskineziya, indeks atrofii, stereotaksicheskaya destrukciya, neyrodegenerativnoe zabolevanie
1. Mikhalevich IM, Yuryeva TN. (2015). Discriminant analysis in biomedical research (using Statistica Software Package in medical researches): manual for physicians [Diskriminantnyy analiz v mediko-biologicheskikh issledovaniyakh (ispol’zovanie v meditsinskikh issledovaniyakh s primeneniem PPP Statistica): posobie dlya vrachey]. Irkutsk, 44 p.
2. Mikhalevich IM. (2009). Regression analysis ((using Statistica Software Package in medical researches): manual for physicians [Regressionnyy analiz (ispol’zovanie v meditsinskikh issledovaniyakh s primeneniem PPP Statistica): posobie dlya vrachey]. Irkutsk, 32 p.
3. Sayutina SB, Shprakh VV, Rozhkova NY. (2013). Citicoline in complex therapy of Parkinson’s disease [Tsitikolin v kompleksnoy terapii bolezni Parkinsona]. Tikhookeanskiy meditsinskiy zhurnal, (4), 76-78.
4. Sayutina SB, Shprakh VV. (2011). Possibilities of complex correction of nonmotor manifestations of Parkinson’s disease in combination with discirculatory encephalopathy [Vozmozhnosti kompleksnoy korrektsii nemotornykh proyavleniy bolezni Parkinsona v sochetanii s distsirkulyatornoy entsefalopatiey]. Materialy II natsional’nogo kongressa po bolezni Parkinsona i dvigatel’nym rasstroystvam. Moskva, 359-363.
5. Coban A, Hanagasi HA, Karamursel S, Barlas OB. (2009). Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson’s disease. J. Neurosurg., 23 (1), 23-29. doi: 10.1080/02688690802507775.
6. Guridi JI, Obeso JA, Rodriguez-Oroz MC, Lozano AA, Manrique M. (2008). L-dopa-induced dyskinesia and stereotactic surgery for Parkinson’s disease. Neurosurgery, 62 (2), 311-323, discussion 323-5. doi: 0.1227/01.neu.0000315998.58022.55.
7. Jourdain VA, Schechtmann G, Di Paolo T. (2014). Subthalamotomy in the treatment of Parkinson’s disease: clinical aspects and mechanisms of action. J. Neurosurg., 120 (1), 140-151. doi: 10.3171/2013.10.JNS13332.
8. Munhoz RP, Cerasa A, Okun MS. (2014). Surgical treatment of dyskinesia in Parkinson’s disease. Front. Neurol., 29 (5), 65. doi: 10.3389/fneur.2014.00065.
9. Obeso JA, Jahanshahi M, Alvarez L, Macias R, Pedroso I, Wilkinson L, Rothwell JC. (2009). What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson’s disease. Exp. Neurol., 220 (2), 283-292. doi: 10.1016/j.expneurol.2009.08.030.
10. Sako W, Miyazaki Y, Izumi Y, Kaji R. (2014). Which target is best for patients with Parkinson’s disease. A meta-analysis of pallidal and subthalamic stimulation. J. Neurol. Neurosurg. Psychiatry, 85 (9), 982-986. doi: 10.1136/jnnp-2013-306090.
11. Tarsy D. (2009). Does subthalamotomy have a place in the treatment of Parkinson’s disease? J. Neurol. Neurosurg. Psychiatry, 80 (9), 939-940. doi: 10.1136/jnnp.2008.163949.
